Psa rise

It isn't a popular thing to write on here but the trial data showed that if Abbi fails then Enza will also fail, and vice versa. That is why NICE made the decision not to allow both ( as quoted above). There are people who find it hard to believe or accept, because Abbi and Enza work in very different ways but generally, the most important thing at that stage is for the oncologist to use all the information about a man's disease behaviour, progression, what worked well or not, etc to judge whether Abbi or Enza is going to be the best bet.

There are men on here who fought for one after the other, but I suspect this is an emotional rather than rational response ... the idea that there were two drugs to try and then suddenly the option of both was ripped away rather than any evidence that it would extend their life. Or perhaps not everyone reads the trial reports.

Alathays continues to campaign for it in Ireland but his disease is so atypical it would probably be worth the fight in his case!